Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The success rate of Assisted Reproductive Technology (ART) hovers around 30%. Even in successful cases, the incidence of multiple births, due to multiple embryo transfer, and their associated morbidity, is dangerously high. Now a new paper reveals how laser technology is being used to make ART safer and more efficient.

Lien Davidson is a DPhil student at the Nuffield Department of Obstetrics & Gynaecology exploring the use of infra-red lasers as an investigative tool for developmental biology and early stage embryos © Nuffield Department of Obstetrics & Gynaecology
Lien Davidson is a DPhil student at the Nuffield Department of Obstetrics & Gynaecology exploring the use of infra-red lasers as an investigative tool for developmental biology and early stage embryos

How laser techniques are helping to overcome infertility 

An estimated one in seven couples experience difficulty conceiving.  Assisted reproductive technology (ART) has been rapidly expanding since the birth of Louise Brown, the first test tube baby, in 1978. Although an increasingly complex array of laboratory skills and procedures have been developed for infertility treatments, the success rate of ART hovers around 30%. Even in successful cases, the incidence of multiple births, due to multiple embryo transfer, and their associated morbidity, is dangerously high.

In an attempt to make ART safer and more efficient, international medical practice is trending towards single embryo transfers and the use of innovative, sophisticated technologies to identify promising gametes and embryos with the highest potential to generate a pregnancy. Laser technology is increasingly being used to accomplish these aims and improve the efficiency of ART. The use of laser technology reduces procedure times and increases consistency and reproducibility of traditional ART techniques such as embryo biopsy and assisted embryo hatching.

 Download full paper here 

Beam me up, baby: exploring the use of lasers in assisted reproductive technologies (Lien M. Davidson, Celine Jones, Tracey Griffiths and Kevin Coward)

ABOUT THE AUTHORS 

Lien Davidson from the Nuffield Department of Obstetrics & Gynaecology is a recent graduate of the MSc in Clinical Embryology and is now a DPhil student in Dr Kevin Coward’s research group, which explores the use of infra-red lasers as an investigative tool for developmental biology and early stage embryos. Celine Jones, Laboratory Manager for the Coward group and for the MSc in Clinical Embryology, has a broad range of research interests including the cellular, biochemical, and molecular mechanisms of oocyte activation. Tracey Griffiths is a Senior Clinical Embryologist with the Oxford Fertility Unit, with special responsibility for training and the Unit’s embryo biopsy service.

Dr Kevin Coward is Director of the Oxford MSc in Clinical Embryology and Principal Investigator in the Nuffield Department of Obstetrics and Gynaecology (University of Oxford). Dr Coward’s research interests include oocyte activation deficiency, male factor infertility, the potential detrimental effects of ART technologies upon gametes, and the development of novel nanoparticle-mediated delivery systems for gametes and embryos. The latest addition to his research portfolio involves the use of lasers in ART and incorporates collaboration with Research Instruments Ltd (Falmouth, Cornwall).

Similar stories

MitOX 2023- 21st April

The Nuffield Department of Women's & Reproductive Health invites you to MitOX 2023 on Friday 21st April. Our annual conference for researchers with an interest in mitochondria from academia and pharma. This year's event will be 'hybrid', so you can join in-person or virtually!

Award Winning Podcast

‘Unheard of – The hidden voice of Endometriosis ’ the podcast series co-hosted by Danielle Perro (Postdoctoral Researcher in Epidemiology) and Magda Mareckova (DPhil student) has been recognised by the Wellcome Centre for Human Genetics, with a Public Engagement with Research Project Award.

What is the impact of heavy menstrual bleeding on female health and well-being?

Many of us have no idea whether or not our period is “normal”. It’s no wonder, since not only is everyone different, but the stigma still keeps many of us from asking questions or discussing what we go through every month with friends and family. Principal Investigator Prof Suzannah Williams and DPhil student Tomi Adeniran explore what heavy periods can mean in their article published in The Conversation.

Women's Health Strategy for England Launched

The government has published the first ever Women's Health Strategy for England to tackle the gender health gap. Menopause, Endometriosis, Contraception and Fertility treatment are highlighted as some of the top issues women have asked for action on. The Nuffield Department of Women's & Reproductive Health welcome and fully support this bold and exciting strategy to help improve the health of millions of women in England.

Prof Christian Becker wins Clinical Science Award at ESHRE 2022

Congratulations to Professor Christian Becker who was presented with a Clinical Science Award for best oral presentation at the ESHRE 38th Annual Meeting in Milan, Italy this week.

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

Varicose veins are a very common manifestation of chronic venous disease, affecting over 30% of the population in Western countries. In America, chronic venous disease affects over 11 million men and 22 million women aged 40–80 years old. Left untreated it can escalate to multiple health complications including leg ulcers and ultimately amputations. A new international study by Oxford researchers published on 2nd June 2022 in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.